ResearcherNo recent work listed

Anneliese Schneider

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3350-5106; OpenAlex author ID A5109916807. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper

Papers 1

Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Last author DOI 10.1111/j.1349-7006.2011.01917.x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Karl‐Hermann Schlingensiepen · 1 shared paper, 2011 · strength 0.03
- Paper Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. DOI 10.1111/j.1349-7006.2011.01917.x ↗
Sven Arke Lang · 1 shared paper, 2011 · strength 0.03
- Paper Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. DOI 10.1111/j.1349-7006.2011.01917.x ↗
Christian Moser · 1 shared paper, 2011 · strength 0.03
- Paper Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. DOI 10.1111/j.1349-7006.2011.01917.x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.